Larvol Delta - Anixa-Biosciences-and-Cleveland-Clinic-Present-Positive-Data-for-Phase-1-Study-of-Breast-Cancer-Vaccine

alpha-lactalbumin vaccine - Anixa Biosci, Cleveland Clinic

https://www.prnewswire.com/news-releases/anixa-biosciences-and-cleveland-clinic-present-positive-data-for-phase-1-study-of-breast-cancer-vaccine-301799180.html

Apr 17, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next